* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * INFORMATION ALERT * * * * Produced by: Saskatchewan Human Resources, * * Labour and Employment * * Provided by: Canadian Centre for Occupational Health and Safety * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * MEDICAL MONITORING OF WORKERS EXPOSED TO ORGANOPHOSPHORUS PESTICIDES *** MODE OF ACTION: *** Organophosphorus pesticides kill target insects, ticks, and mites by inhibiting the activity of the enzyme acetylcholinesterase. This results in death by asphyxiation. Unfortunately, these insecticides can have a similar effect on warm blooded animals, including man. They are readily absorbed through breathing of vapour, ingestion, or skin contact. *** REGULATION: *** Section 67 of 'The Occupational Health and Safety Regulations' requires the employer to take all practicable steps to prevent harm to workers as a result of exposure to a substance. Biological monitoring is the only means of ensuring that the exposure to an organophosphorus pesticide is not excessive. The following recommendations are intended to assist in the monitoring of exposure and identification of harmful effects. *** SYMPTOMS: *** The continuing daily absorption of organophosphorus pesticides at intermediate dosage may cause an influenza-like illness characterized by weakness, anorexia and malaise. Headache, dizziness, weakness, incoordination, muscle twitching, tremor, nausea, abdominal cramps, diarrhoea and sweating are common early symptoms. Blurred or dark vision, confusion, tightness in the chest, wheezing, productive cough and pulmonary edema may occur. Incontinence, unconsiousness and convulsions indicate very severe poisoning. Slow heartbeat, salivation and tearing are common syptoms of severe poisoning. Toxic psychosis, with manic or bizarre behaviour, has led to a misdiagnosis of acute alcoholism. *** BIOLOGICAL MONITORING: *** Changes in cholinesterase levels can provide an estimation of exposure. Both plasma (pseudo) cholinsterase and erythrocyte (true) cholinesterase activities are affected. There is, however, a large variation in normal levels from one individual to another. It is essential then, that workers who are to be monitored have at least one pre-exposure estimation of both plasma and erythrocyte cholinesterase activities. This will provide a baseline against which future estimations can be compared. RECOMMENDATIONS FOR A MONITORING PROGRAM Workers who have only sporadic exposure (a day or two at a time several times a year) should not require routine monitoring of cholinesterase. Workers who will have continuous exposure should have plasma (pseudo) cholinsterase determinations monthly. It could be useful, however, to test more frequently (every ten days) at the beginning of a new operation in order to evaluate the soundnesss of the work procedures followed. A reduction of 25% or more in pseudocholinesterase levels is strong evidence of excessive absorption. If a medical examination reveals other signs and syptoms of overxposure, a physican may decide to temporarily remove the worker from exposure. A reduction of 50% from base line is usually accompanied by syptoms and is indication for immediate removal from exposure. Weekly checks of the enzyme level should be made until the cholinesterase activity returns to at least 75% of normal. This level in the absence of other signs and symptoms would permit a person to resume working with the pesticide. It is of course important to examine the work procedures of that person to eliminate the causes of exposure. Depression of pseudocholinesterase levels usually persist for several days to a few weeks. The erythrocyte ezyme activity remains depressed longer, sometimes 1-3 months and would be an appropriate measurement following severe illness. Plasma cholinsterase levels can also be suppressed by some medications and by liver disease. *** HOW CAN TESTING BE DONE: *** 5 ml of heparinized whole blood is requried per sample. Arrangements should be made with the Provincial Laboratory (Dr. H.E. Robertson Laboratories) in Regina for the analysis of samples and the reporting of results back to a physician. Bulletin TU 17, July 1990 * * * * * * * * * * * * * * * * * * * * * * * *